Africa: Anti-Malarial Drug Resistance Is Making Malaria Normal Again

Despite Egypt being certified as malaria-free, the parasite is developing resistance to treatments, potentially costing Africa $127 billion in lost GDP by 2030 and 600,000 lives annually. The emergence of resistance to artemisinin-based therapies poses a significant threat, with key donors calling for urgent action to make alternative treatments more accessible and affordable. Malaria continues to strain African health systems and hinder economic development, highlighting the pressing need for increased funding and research to combat this evolving threat.

Full Article